Klindamycin Evolan (Clindamycin)

Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This prevents peptide chain elongation, resulting in a bacteriostatic effect that stops the growth of susceptible anaerobic and Gram‑positive organisms.

The dosage and duration of Klindamycin Evolan are set by the prescribing clinician based on the severity of infection, patient weight, renal and hepatic function, and local treatment guidelines. Patients should follow the prescriber’s instructions exactly.

Safety data for clindamycin in pregnancy and lactation are limited, and the product carries an unknown pregnancy category. Healthcare providers should weigh potential benefits against risks and consider alternative therapies when appropriate.

To request Klindamycin Evolan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Clindamycin is a lincosamide that offers strong activity against anaerobic bacteria, often used when metronidazole is contraindicated or ineffective. Compared with metronidazole, clindamycin may have a higher risk of gastrointestinal side effects but can be preferable for patients with metronidazole intolerance.

Store Klindamycin Evolan at temperatures below 25 °C in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

Klindamycin Evolan is applied intravaginally as directed by the prescriber, typically using a pre‑filled applicator. The patient should insert the medication into the vagina and retain it for the prescribed period, usually before bedtime to maximize local exposure.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they develop rash, fever, persistent diarrhea or breathing difficulties.

Individuals with a known hypersensitivity to clindamycin, lincomycin or other lincosamide antibiotics should avoid this product. It is also contraindicated in patients with a history of severe colitis or those who have experienced serious adverse reactions to clindamycin previously.